Estudo Safira: reflexões sobre a prevalência e os padrões de tratamento de fibrilhação auricular e risco cardiovascular em 7500 indivíduos com 65 ou mais anos

Kirchhof P, Benussi S, Kotecha D, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. Hobbs, 2005, A randomised controlled trial and cost‐effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study, Health Technol Assess., 9, 10.3310/hta9400 Sposato, 2015, Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta‐analysis, Lancet Neurol., 14, 377, 10.1016/S1474-4422(15)70027-X Kishore, 2014, Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta‐analysis, Stroke., 45, 520, 10.1161/STROKEAHA.113.003433 Bonhorst, 2010, Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the Fama study, Rev Port Cardiol., 29, 331 Heeringa, 2006, Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, Eur Heart J., 27, 949, 10.1093/eurheartj/ehi825 Cea-Calvo, 2007, Prevalence of atrial fibrillation in the Spanish population aged 60 years or more. The PREV‐ICTUS study, Rev Esp Cardiol., 60, 616, 10.1157/13107118 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor‐based approach: the euro heart survey on atrial fibrillation, Chest., 137, 263, 10.1378/chest.09-1584 Pisters, 2010, A novel user‐ friendly score (HAS‐BLED) to assess 1‐year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey, Chest, 138, 1093, 10.1378/chest.10-0134 Connolly, 2008, Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range, Circulation., 118, 2029, 10.1161/CIRCULATIONAHA.107.750000 Pathak, 2014, Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST‐AF cohort study, J Am Coll Cardiol, 64, 2222, 10.1016/j.jacc.2014.09.028 Abed, 2013, Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial, JAMA., 310, 2050, 10.1001/jama.2013.280521